2023年5月8日

发表:2023 - 5月8日09:28更新:08年5月,2023 - 09:28三星电子董事长李在镕与旗舰开创性的创始人兼首席执行官Noubar Afeyan,也是现代化的创始人之一,2021年11月在美国公司的总部。(三星电子)三星电子董事长李在镕,三星集团的实际领导者,发誓要推动全国最大的企业集团迅速发展的生物制药企业“重复半导体的成功故事,”当他会见的主要生物制药公司在美国,该公司周日说。前往美国的东海岸,是世界上领先的生物制药集群,李明博会见了全球生物制药和创业孵化公司首脑讨论如何促进生物制药行业的竞争力和联合商业机会,三星说。三星集团在2011年创建了三星生物制剂,开发了公司成为世界1号合同开发和制造组织已敲定海侵处理辉瑞和现代化生产COVID-19疫苗后的大流行。李在一系列的会议,会见了强生公司主席华金Duato,百时美施贵宝公司首席执行官乔瓦尼Caforio旗舰开创性的创始人兼首席执行官Noubar Afeyan,首席执行官魏巴赫和工具论的首席执行官凯文•阿里,三星说。“起点并不重要。大胆的和病人企图将决定胜利或失败,”李说。“我们进行的成功的DNA的生物制药行业的半导体制造成功的。”年代amsung said Lee's meetings with the industry leaders come with the aim to strengthen the company's global connection and add weight to its biopharmaceutical and biotech business, one of the future growth drivers. J&J is a top-tier biopharmaceutical firm boasting a long history of 140 years, and a major client of Samsung. BMS is a company that provided the "initial drive" for the Korean firm to promote its biopharma business, by making the first production order for pharmaceutical products in 2013, Samsung explained. As for Afeyan, the head of Flagship Pioneer, he forged the production contract of mRNA vaccines to contribute to overcoming the COVID-19 pandemic crisis in Korea. Afeyan is also the co-founder of Moderna. Biogen is the company that jointly established Samsung Bioepis, the biopharmaceutical arm of Samsung Biologics, in 2012. While it handed over all of its stakes in Bioepis to Biologics last year, Biogen still works closely with Samsung, being in charge of distribution and sales of Samsung’s autoimmune diseases treatments, the company added. The Korean giant said it was able to develop Samsung Biologics as the world's top CDMO after a decade, thanks to its speedy decision-making and bold investment, and with overwhelming manufacturing technology, the company said. Lee's wide network with big pharmaceutical companies will play in as a "leverage" for cooperation, to produce the drive for future growth, Samsung said. After the meeting with the industry leaders, Lee met with the employees of Samsung's sales corporate headquarters in the US to inspect location operations and encourage staff members there. Lee's visit to the US comes for the first time since he was promoted to chairman in November last year, as he joined an economic delegation accompanying South Korean President Yoon Suk Yeol on his state visit in April. Lee has extended the trip to the US, as the date for his next trial in Seoul over the 2015 merger of two Samsung affiliates was delayed to resume on May 26. By Jo He-rim ( herim@heraldcorp.com )